Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Contingent Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹1,358 Cr₹1,290 Cr₹311 Cr₹159 Cr₹158 Cr

What is the latest Contingent Liabilities ratio of AUROBINDO PHARMA ?

The latest Contingent Liabilities ratio of AUROBINDO PHARMA is ₹1,358 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹1,358 Cr
Mar2025₹1,290 Cr
Mar2024₹311 Cr
Mar2023₹159 Cr
Mar2022₹158 Cr

How is Contingent Liabilities of AUROBINDO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2026 ₹1,358 Cr
5.28
Mar2025 ₹1,290 Cr
314.42
Mar2024 ₹311 Cr
96.39
Mar2023 ₹159 Cr
0.50
Mar2022 ₹158 Cr -

Compare Contingent Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹90,697.4 Cr -5.1% -9.2% 43.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -0.2% -4.9% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr 1.3% -2.3% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.5% -5.8% 29.3% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -4.2% -14.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 1.9% 5.7% 0.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-5.1%

-9.2%

43.8%

SENSEX

0.9%

-0.8%

-10.5%


You may also like the below Video Courses